Medications

US approves breakthrough hepatitis C drug (Update)

U.S. health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.

Genetics

US tells 23andMe to halt sales of genetic test

The U.S. Food and Drug Administration is ordering genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is backed by science.

Diseases, Conditions, Syndromes

Salad mix production halted after stomach bug

(AP)—A California company has voluntarily suspended production of salad mix at a Mexico processing facility that has been linked to an outbreak of stomach illnesses in Iowa and Nebraska.

Diseases, Conditions, Syndromes

Tick-borne illness babesiosis a hazard for seniors: FDA

(HealthDay)—A tick-borne illness that can be severe or fatal among seniors, newborns and people with weakened immune systems is becoming more common in certain parts of the United States, federal health officials warn.

Medications

US: Morning-after pill OK for ages 15 and up (Update)

The U.S. government on Tuesday lowered to 15 the age at which girls can buy the morning-after pill without a prescription and said the emergency contraception no longer has to be kept behind pharmacy counters.

Health

US supreme court rejects challenge to new cigarette labeling

(HealthDay News) —The U.S. Supreme Court on Monday rejected a tobacco industry challenge to a controversial 2009 federal law that mandates graphic warning labels on cigarettes. The high court refused to hear the case, essentially ...

page 3 from 8